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Productive infection with herpes simplex virus (HSV) type 1 is limited by both innate and adaptive immune mechanisms.
The purpose of the current study was to determine whether these mechanisms also play a role in the establishment of latent
HSV infection. First we examined the trigeminal ganglia (TG) of severe combined immunodeficiency (SCID), interferon-g
knockout (GKO), and beige (a strain deficient in natural killer cell activity) mice following ocular inoculation with HSV. Although
infection of SCID mice was invariably lethal, we consistently found latently infected neurons in the TG of these animals at 2–4
days postinoculation. HSV infection of GKO and beige mice, while not lethal, was characterized by a greater number of
productively infected TG neurons and/or a delay in the time to peak productive infection compared to C57BL/6 controls.
However, as assayed by both in situ hybridization for LAT expression and quantitative PCR (Q-PCR) for viral DNA, we found
that HSV established a latent infection in GKO and beige mice as efficiently as in C57BL/6 controls. We subsequently
examined the TG of “HSV-sensitive” strains of mice (Swiss–Webster, CBA, and BALB/c) following ocular infection with HSV.
At the peak of acute ganglionic infection the number of productively infected TG neurons in each of these mouse strains was
about sevenfold greater than in the “HSV-resistant” strain C57BL/6, consistent with previously reported differences in
susceptibility to lethal challenge with HSV. However, as assayed by both in situ hybridization for LAT and Q-PCR for viral DNA,
we found that HSV established a latent infection in Swiss–Webster, CBA, and BALB/c mice as efficiently as in C57BL/6
controls. We conclude that HSV efficiently establishes latent infection in the TG of mice in the absence of innate and adaptive
immune mechanisms that are essential for limiting productive viral infection. © 2000 Academic Press
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Peripheral inoculation of immune-competent mice with
herpes simplex virus (HSV) type 1 results in productive
infection of peripheral tissues followed by retrograde
axonal transport of HSV to sensory ganglia (Wagner and
Bloom, 1997). Infectious virus can be recovered from
these ganglia, but for only about 7 days. After this HSV
persists in ganglionic neurons as a latent infection, char-
acterized by limited transcription of the viral genome
except for latency-associated transcripts (LAT) that ac-
cumulate to high copy number in the nuclei of infected
cells (Stevens et al., 1987). We refer to the process by
which infection with HSV results in this pattern of viral
gene expression as establishment of latency. An inter-
esting feature of latently infected neurons is that they can
be found as early as 2 days postinoculation (p.i.) (Mar-
golis et al., 1992; Speck and Simmons, 1992; Steiner et
al., 1990); extremely early in the course of acute gangli-
onic infection and well before clearance of productively
infected cells by the immune system. This observation
raises questions about the role of immune mechanismsa
k
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17in the establishment of latent infection of primary sen-
sory neurons.
The host immune response to primary infection with
HSV has been the focus of extensive investigation and
consists of both innate and adaptive mechanisms
(Schmid and Rouse, 1992; Simmons et al., 1992; Welsh
and Sen, 1997). The innate mechanisms, including up-
regulation of interferon-g (IFN-g) and activation of natural
iller (NK) cells, are observed soon after primary infec-
ion. This is followed by adaptive mechanisms which
ontrol and clear productive infection through the actions
f HSV-specific B and T lymphocytes (Chan et al., 1990;
Rossol-Voth et al., 1991; Smith et al., 1994; Sprecher and
Becker, 1990). Immunocytochemical and molecular anal-
ysis of latently infected sensory ganglia reveals evidence
of ongoing stimulation of the immune system as evi-
denced by focal T-cell infiltrates and elevated levels of
cytokine mRNAs, including interleukin (IL)-2, IL-10, tumor
necrosis factor (TNF)-a, and IFN-g (Cantin et al., 1995;
alford et al., 1997; Liu et al., 1996). The trigger for these
esponses has not yet been determined, but they appear
o be diminished in latently infected mice that receive
hronic acyclovir therapy (Halford et al., 1997).
While both innate and adaptive immune mechanisms
re integral to clearing productive HSV infection, it is not
nown what role, if any, these mechanisms play in the
0042-6822/00 $35.00
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18 ELLISON ET AL.establishment of latent HSV infection. Clearly, an anti-
body response is not essential for establishment of la-
tent HSV infection because latent infections are ob-
served in humans with agammaglobulinemia and in an-
tibody-deficient experimental animals (Kapoor et al.,
982; Sekizawa et al., 1980). Furthermore, functional B
nd T lymphocytes do not appear to be required for the
stablishment of latent HSV infection since HSV estab-
ishes a latent infection in ganglia of severe combined
mmunodeficiency (SCID) mice (Gesser et al., 1994).
These results are not surprising since latently infected
neurons are found in primary sensory ganglia at times
well before adaptive immune responses have time to
develop (Margolis et al., 1992; Speck and Simmons,
1992). Thus, if the immune response to primary HSV
infection plays a role in the establishment, it is most
likely not by adaptive mechanisms.
IFN-g and NK cells, which are central to the innate
mmune response, have been reported to limit productive
SV infection. IFN-g has a multipotent antiviral effect,
ncluding inhibition of HSV replication and activation of
mmune cells for control and clearance of infection (Fe-
uchi et al., 1989; Smith et al., 1994). In mouse models,
verexpression of ocular IFN-g protects mice from lethal
infection with HSV (Geiger et al., 1994), and a null muta-
tion of the IFN–g gene (GKO mice) renders them highly
usceptible to HSV-mediated neuronal apoptosis and the
evelopment of herpetic stromal keratitis (HSK) (Bouley
t al., 1995; Dalton et al., 1993; Geiger et al., 1997). NK
cells are able to lyse HSV-infected cells in vitro and
passive transfer of NK cells to immunosuppressed mice
confers protection from lethal infection with HSV (Rager-
Zisman et al., 1987). Mice with a mutation of the beige
ene have impaired NK cell, mononuclear phagocyte,
nd granulocyte function (Elin et al., 1974; Gallin et al.,
974; Roder and Duwe, 1979) and exhibit increased sen-
itivity to several microbial and viral infections (Hoskin et
l., 1991). While beige mice are no more sensitive to
ethal HSV infection and the development of HSK than
mmunocompetent controls (Morahan et al., 1982; Tame-
is et al., 1994), the course of productive infection with
SV and establishment of HSV latency has not been
xamined. Reproducible differences in susceptibility to
ethal HSV-1 infection have been described among com-
on inbred strains of mice (e.g., BALB/c, CBA, C57BL/6)
Kastrukoff et al., 1986; Lopez, 1975). While the mecha-
ism(s) is not well defined, strain-associated differences
n resistance have been linked to variations in the im-
une response (Engler et al., 1982), the host cell’s ability
o permit viral replication (Thomas et al., 1991), and the
resence of certain MHC-linked genes (Simmons, 1989).
f particular relevance to the present study, establish-
ent of HSV latent infection has not been compared in
ny of the aforementioned genetically distinct mouse
trains.
In this study we examined establishment of latent HSVnfection following ocular inoculation in (i) immunodefi-
ient (SCID, GKO, and beige, (ii) HSV-sensitive (BALB/c,
BA, Swiss-Webster), and (iii) HSV-resistant (C57BL/6)
trains of mice. In the three immunodeficient lines, latent
nfection of the trigeminal ganglia (TG) was established
s efficiently as in coisogenic immunocompetent con-
rols. Similarly, in the HSV-sensitive strains, latent infec-
ion was established as efficiently as in the more resis-
ant C57BL/6 strain. These results support the notion that
mmune mechanisms play little or no role in establish-
ent of latent HSV infection.
RESULTS
ffect of the titer of peripheral viral inoculum on HSV
anglionic infection
It has been an ongoing concern of ours that relatively
mall differences in inoculum size might effect the es-
ablishment of latency, in part because differences in
noculum size alter the kinetics and magnitude of the
mmune response to infection (Altmann and Blyth, 1985;
orrow and Oldstone, 1997; Scott, 1993). In order to
btain a better understanding of the relationship be-
ween the titer of the peripheral HSV inoculum and the
fficiency of establishment of HSV latent infection
wiss–Webster mice were inoculated with varying titers
f HSV strain KOS (1.5 3 102 to 1.5 3 106 PFU/eye) and
, 4, 5, 6, and 21 days later infected TG were removed
nd assayed for productive and latent HSV infection.
roductively infected neurons were identified by immu-
ofluorescence using FITC-labeled anti-HSV antisera,
ith the time to peak productive infection defined as the
ime at which the maximum number of HSV antigen-
ositive neurons are observed. Latently infected neurons
ere identified by in situ hybridization using a LAT-
pecific 35S-labeled riboprobe.
Results of these experiments are summarized in Table
and highlight several interesting features of the effect
f the titer of the HSV inoculum on productive and latent
anglionic infection. First, at peripheral inocula less than
.5 3 102 we did not reproducibly achieve infection of
trigeminal neurons. This suggests that local mecha-
nisms are capable of limiting access of the virus to
sensory nerve endings when the peripheral inoculum is
relatively small. Second, time to peak productive neuro-
nal infection of the trigeminal ganglion with HSV was
directly related to the size of the viral inoculum, with
earlier peak infections occurring in mice infected with
higher titers of HSV. Whereas productive neuronal infec-
tion of the TG peaked 3 days p.i. with 1.5 3 106 PFU of
SV, this peak did not occur until 4 days p.i. with 1.5 3
04 PFU of HSV and 6 days p.i. with 1.5 3 102 PFU of
HSV. Third, despite the wide range of inoculating titers of
HSV (greater than 4 log units), there was only modest
differences in the number of productively infected and
latently infected ganglionic neurons in each of the ex-
t
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19ESTABLISHMENT OF LATENT HSV IN IMMUNODEFICIENT MICEperimental groups. Furthermore, the ratio of productive
to latently infected neurons was similar for all inocula
over 1.5 3 102 PFU. Thus, once past a relatively low
hreshold, increasing the size of the peripheral inoculum
ad only a modest effect on the number of productively
nd latently infected neurons and little or no effect on the
atio of these two patterns of infection.
ole of B and T lymphocytes in establishment of
atent HSV infection
Despite the susceptibility to lethal infection with HSV,
esser et al. found that HSV establishes a latent infec-
ion in the TG of SCID mice as efficiently as in control
B17 mice at 4–6 days p.i. (Gesser et al., 1994). Because
f the importance of these findings to our ongoing work
n the role of the host neuron in regulating the outcome
f HSV infection, we sought to extend this work by
xamining the pattern of viral gene expression in the TG
eurons of SCID mice 2–4 days p.i., corresponding to the
ime frame during which HSV is thought to establish
atent infection of ganglionic neurons (Margolis et al.,
992; Speck and Simmons, 1992; Steiner et al., 1990). To
ccomplish this, mice were infected with KOS/62, an
SV construct in which the LAT promoter drives expres-
ion of the lacZ gene, and tissue sections of acutely
nfected TG were analyzed by dual immunofluorescence.
roductively infected neurons were identified by expres-
ion of viral-specific proteins (HSV antigen-positive); la-
ently infected neurons were identified by the expression
f b-gal in the absence of viral-specific proteins (b-gal-
positive/HSV antigen-negative). The use of KOS/62 in
these studies allowed us to readily differentiate between
these two patterns of viral gene expression during the
TABLE 1
Effect of Viral Titer on the Number of Productively
and Latently Infected Neuronsa
Titer of HSV inoculum
(PFU/eye)
HSV antigen-positive
neurons (peak day
of infection)
LAT-positive
neurons Ratiob
1.5 3 102 1094 (d6) 221 5:1
4.5 3 102 1358 (d5) 561 2.4:1
1.5 3 103 2326 (d4) 1073 2.2:1
1.5 3 104 1869 (d4) 856 2.2:1
1.5 3 106 3484 (d3) 1202 2.9:1
a Trigeminal ganglia from five mice were pooled, fixed, frozen in OCT
ompound, serially sectioned, and collected on five alternate sets of
lides. HSV antigen-positive (3–7 and 21 days p.i.) and LAT-positive (21
ays p.i.) neurons were determined as described under Materials and
ethods. The total number of positive neurons on one set of slides
representing one-fifth of all sections) is reported.
b Expressed as the number of antigen-positive neurons to the num-
er of LAT-positive neurons.very early stages of acute ganglionic infection.
The results of our studies on the establishment of 3latent HSV infection in the TG of SCID mice and coiso-
genic BALB/c controls are summarized in Table 2. At all
three time points studied we found a very similar number
of neurons and percentage of infected neurons with a
latent pattern of HSV gene expression (b-gal positive/
SV antigen negative) in the TG of SCID mice as in
ALB/c controls. Thus, consistent with the work of
esser et al. (1994), our results indicate that B and T
ymphocytes appear to play little or no role in the establish-
ent of latency at early time points after primary infection.
ole of IFN-g and natural killer cells in establishment
of latent HSV infection
We next sought to determine the role of IFN-g and NK
cells in establishment of latent HSV infection. To accom-
plish this, we examined the TG of GKO and beige mice
following ocular inoculation with HSV strain KOS. While
not lethal, HSV infection of these mice was characterized
by a greater number of productively infected TG (HSV
antigen-positive) neurons and/or a delay in the time to
peak productive TG infection compared to C57BL/6 con-
trols (Fig. 1 and Table 3). At 21 days p.i., no HSV antigen-
positive neurons were found but LAT-positive neurons
were abundant (Fig. 1). Thus, similar to C57BL/6 controls,
productive HSV infection resolves by 21 days p.i., but a
latent infection persists in both GKO and beige mice.
We next examined the efficiency with which HSV es-
tablishes a latent infection in the TG of GKO and beige
mice compared to C57BL/6 controls. This was deter-
mined by two different methods. First, we assayed the
number of LAT-positive neurons in the TG of latently
infected mice by in situ hybridization. To accomplish this
with a minimum of sampling bias, we batched tissue
TABLE 2
Number of Acutely and Latently Infected Neurons during Estab-
ishment of Infection in the Absence of Functional B and T Lympho-
ytesa
Mouse
strain
Days
p.i.
HSV antigen-
positive neurons
Exclusively
b-gal-positive
neurons
b-gal-positive
(%)b
BALB/c 2 882 34 3.7%
3 5893 27 0.4%
4 5943 37 0.6%
SCID 2 665 17 2.4%
3 7769 36 0.5%
4 4467 36 0.8%
a Trigeminal ganglia from five mice were pooled, fixed, frozen in OCT
ompound, serially sectioned, and collected on five alternate slides.
dentification of HSV antigen-positive and b-gal-positive neurons was
determined by colabeling as described under Materials and Methods.
The total number of positive neurons on one set of slides (representing
one-fifth of all sections) is reported.b Exclusively b-gal-positive/(HSV antigen-positive 1 b-gal-positive)
100.
a
a
c
t
f
C
I
i
s
l
aterials
(
20 ELLISON ET AL.from each experimental group, sectioned each batch in a
serial fashion, and then assayed every fifth tissue sec-
tion for LAT-positive neurons. As analyzed in this manner
we found similar numbers of LAT-positive neurons in TG
of GKO and beige mice compared to C57BL/6 controls
(Table 3). Second, we determined the amount of viral
DNA in the TG of latently infected mice by quantitative
PCR (Q-PCR), which in our hands gives reproducibly
linear results in assaying between approximately 5 3 105
and 5 3 102 copies of HSV DNA per TG (Fig. 2). As
FIG. 1. Representative examples of HSV-infected TG tissue sectio
expression by in situ hybridization (A9–C9). TG from five C57BL/6 (A,
immunohistochemistry and in situ hybridization as described under M
T
Number of Productively and Latently Infected Neurons in Trigem
Experiment Mouse strain
Peak day of
productive
infection
Pr
HSV antig
neurons
1 C57BL/6 3 6
GKO 4 21
Beige 4 6
2 C57BL/6 3 5
Swiss–Webster 3 34
BALB/c 4 37
CBA 4 42a TG from five mice were pooled, fixed, frozen in OCT compound, serially s
3–5 and 21 days p.i.) and LAT-positive (21 days p.i.) neurons were determinednalyzed in this manner we found equivalent or greater
mounts of viral DNA in TG of GKO and beige mice
ompared to C57BL/6 controls (Table 4). Taken together
hese results indicate that HSV establishes a latent in-
ection in GKO and beige mice as efficiently as in
57BL/6 controls. Thus, despite the important roles that
FN-g and NK cells play in controlling productive HSV
nfection, these components of the innate immune re-
ponse play little, if any, role in the establishment of
atent HSV infection.
ned for HSV antigen by immunohistochemistry (A–C) and LAT RNA
ige (B, B9), and GKO (C, C9) mice were removed and processed for
and Methods.
anglia (TG) of Resistant, Sensitive, and Immunodeficient Micea
ely infected neurons
Latently infected neurons
itive
(n)
Fold difference
vs C57BL/6
LAT-positive
neurons per
TG (n)
Fold difference
vs C57BL/6
— 150 (30) —
3.6 183 (10) 1.2
1.0 174 (10) 1.2
— 110 (10) —
6.2 170 (10) 1.5
6.7 240 (10) 2.2
7.6 118 (10) 1.1ns stai
A9), beABLE 3
inal G
oductiv
en-pos
per TG
0 (40)
5 (10)
2 (10)
6 (10)
8 (10)
3 (10)
7 (8)ectioned, and collected on five alternate slides. HSV antigen-positive
as described under Materials and Methods. n, number of TG assayed.
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21ESTABLISHMENT OF LATENT HSV IN IMMUNODEFICIENT MICEEstablishment of latent HSV infection in inbred and
outbred mouse strains
As an extension of our work with immunodeficient
mouse strains, we sought to determine whether latent
HSV infection is established as efficiently in the TG of
inbred (BALB/c, CBA) and outbred (Swiss–Webster) mice
as in C57BL/6 controls. We chose to study these strains
since they are known to have greater susceptibility to
lethal challenge with HSV than C57BL/6 mice (Altmann
and Blyth, 1985; Kastrukoff et al., 1986; Lopez, 1975).
hile the mechanism(s) is not well defined, strain-asso-
iated differences in resistance to HSV infection have
een linked to variations in the immune response (Engler
t al., 1982), the host cell’s ability to permit viral replica-
ion (Thomas et al., 1991), and the presence of certain
HC-linked genes (Simmons, 1989).
To test whether strain-associated differences in sus-
eptibility to lethal challenge play a role in establishment
f HSV latent infection BALB/c, CBA, Swiss–Webster, and
ontrol C57BL/6 mice were inoculated ocularly with HSV
train KOS, and latent infection of the TG was then
ssayed at 21 days p.i. by in situ hybridization for LAT
expression and Q-PCR for viral DNA (Fig. 2). In addition,
at 3, 4, and 5 days p.i. productive infection of the TG was
assayed by immunofluorescence for the presence of
HSV antigen. As summarized in Table 3, at the peak of
productive ganglionic infection we found six- to eightfold
FIG. 2. Quantification of HSV DNA in latently infected mouse trigemina
fragments of the mouse genomic HPRT and HSV TK genes. Standards
2), 5 3 104 copies per TG (lane 3), 5 3 103 copies per TG (lane 4), 5 3
PCR products from mouse strains as follows: C57BL/6 (lanes 7 and 8),
14), GKO (lanes 15 and 16), beige (lanes 17 and 18), and uninfected S
TABLE 4
HSV DNA Content in Trigeminal Ganglia of Latently Infected
Resistant, Sensitive, and Immunodeficient Mice
Mouse strain (n) a
HSV copies per
trigeminal ganglion
(log10 values)
b
Range
(log10 values)
57BL/6 (18) 3.6 6 0.5 2.8–4.4
KO (12) 4.3 6 0.3c 3.5–4.6
Beige (12) 3.8 6 0.6 2.8–4.5
Swiss–Webster (12) 3.7 6 0.5 2.9–4.3
BALB/c (12) 3.8 6 0.6 2.9–4.8
CBA (12) 3.6 6 0.4 2.9–3.9
a Number of trigeminal ganglia assayed by Q-PCR.
s
S
b Mean 6 standard deviation.
c Statistically different from C57BL/6 by Student’s t test, P , 0.05.more HSV antigen-positive neurons in the TG of BALB/c,
CBA, and Swiss–Webster mice than in C57BL/6 controls.
Despite the greater level of productive infection in
BALB/c, CBA, and Swiss–Webster mice, we found that
latent infection (as assayed by the number of LAT-posi-
tive trigeminal neurons) was established as efficiently as
in C57BL/6 controls (Table 3). Furthermore, at day 21 p.i.
there was no statistical difference in the quantity of viral
DNA in the TG of BALB/c, CBA, and Swiss–Webster mice
compared to C57BL/6 controls (Table 4). Therefore, the
strain-associated differences in susceptibility to lethal
challenge play little or no role in altering the efficient
establishment of latent HSV infection.
Quantifying LAT RNA in latently infected TG of
genetically distinct mouse strains
Recent studies indicate that there may be TG neurons
that harbor latent HSV but express LAT below the limits
of in situ detection (Maggioncalda et al., 1996; Mehta et
al., 1995; Ramakrishnan et al., 1996). These observations
uggest that we may be underestimating the magnitude
f HSV latent infection of the TG by relying solely on the
esults of in situ hybridization studies. For this reason, in
he experiments described above, we assayed latent
nfection of the TG by both quantitative PCR for HSV DNA
nd in situ hybridization. Although a regression analysis
f the data from the two assays did not reach statistical
ignificance (simple regression, R 5 0.303, P 5 0.56)
Fig. 3A), both assays supported the conclusion that
stablishment of HSV latency was not impaired in immu-
odeficient mouse strains. To examine this issue further,
e compared the amount of LAT RNA to the number of
AT-positive neurons in latently infected TG. To accom-
lish this the TG of different lines of mice (GKO, beige,
ALB/c, Swiss–Webster, CBA, and C57BL/6) latently in-
ected with KOS were analyzed by quantitative reverse-
ranscriptase PCR (Q-RT-PCR) (Fig. 4). The results of this
nalysis are summarized in Table 5 and deserve two
omments. First, the amount of LAT RNA detected in the
G of latently infected mice falls on the linear portion of
he Q-RT-PCR standard curve. This is important given the
otential problems in using PCR-based quantitative as-
lia. Representative Q-PCR experimental results showing PCR-amplified
ivalent to 5 3 106 copies per TG (lane 1), 5 3 105 copies per TG (lane
pies per TG (lane 5), and 5 3 101 copies per TG (lane 6). Samples are
Webster (lanes 9 and 10), BALB/c (lanes 11 and 12), CBA (lanes 13 and
ebster (lanes 19 and 20). Reaction mix (lane 21).l gang
are equ
102 coays, especially those with a reverse transcriptase step.
econd, as analyzed by regression analysis (Fig. 3B),
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22 ELLISON ET AL.there was a statistically significant positive correlation
between the number of LAT-positive neurons and the log
amount of LAT RNA in latently infected TG (simple re-
gression, R 5 0.883, P 5 0.0197). These results sug-
est that assaying the number of LAT-positive neurons in
atently infected TG by in situ hybridization is an accurate
ay of determining the relative amount of LAT RNA in
hese tissues. Thus, if there are TG neurons that harbor
atent HSV but express LAT below the limits of in situ
etection, the relative number (percentage of latently
nfected neurons that are LAT-negative) of these LAT-
egative neurons is the same in each of the mouse
trains studied.
DISCUSSION
The major goal of this study was to determine if innate
nd adaptive immune responses to HSV infection pro-
ote establishment of HSV latency. To this end, we have
hown that B and T lymphocytes, IFN-g, and NK cell
unctions associated with the beige gene play little, if
ny, role in the establishment of latent HSV infection in
rigeminal neurons of mice. Furthermore, we have shown
hat the efficiency with which HSV establishes latent
FIG. 3. Regression analysis of the amount of HSV DNA (A) and LAT R
with HSV. Values for the number of LAT-positive neurons, log10 HSV DN
FIG. 4. Quantification of HSV LAT RNA content in latently infected
showing PCR-amplified fragments of mouse G3PDH and HSV LAT RNA.
per TG (lane 2), 1.6 3 108 copies per TG (lane 3), 1.6 3 107 copies per T). Samples are PCR products from mouse strains as follows: C57BL/6 (lanes
BA (lanes 13 and 14), GKO (lanes 15 and 16), beige (lanes 17 and 18), andnfection of the TG is independent of the host’s inherited
usceptibility to lethal viral infection. These findings sup-
ort the hypothesis that the host immune system plays
ittle or no role in the establishment of latent HSV infec-
ion of the mouse TG. This makes it more likely that other
echanisms, such as those mediated by the host neu-
on, are primarily responsible for regulating the outcome
f infection with HSV.
In the course of our studies we found that larger
eripheral viral inocula were associated with earlier time
oints of peak productive ganglionic infection, an unex-
ected observation. We envision at least three different
xplanations for this observation. One possible explana-
ion is that larger inocula induce stronger and earlier
daptive immune responses than smaller inocula, with a
esultant earlier inhibition of viral replication and clear-
nce of productively infected cells. This explanation is
onsistent with the known relationship between inocu-
um size of a given pathogen (including HSV) and the
inetics and magnitude of the adaptive immune re-
ponse to that pathogen (Altmann and Blyth, 1985; Bor-
ow and Oldstone, 1997; Scott, 1993). A second possible
xplanation is that neuronal uptake and retrograde trans-
on the number of LAT-positive neurons in TG of mice latently infected
log10 LAT RNA per TG are from data in Tables 3, 4, and 5, respectively.
e trigeminal ganglia. Representative Q-RT-PCR experimental results
rds are equivalent to 1.6 3 1010 copies per TG (lane 1), 1.6 3 109 copies
4), 1.6 3 106 copies per TG (lane 5), and 1.6 3 105 copies per TG (lanemous
Standa
G (lane
7 and 8), Swiss–Webster (lanes 9 and 10), BALB/c (lanes 11 and 12),
uninfected Swiss–Webster (lanes 19).
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23ESTABLISHMENT OF LATENT HSV IN IMMUNODEFICIENT MICEport of HSV from the periphery to the TG is concentration
dependent, with relatively low inocula requiring multiple
rounds of peripheral replication before efficient retro-
grade-transport of virus can be achieved, thus delaying
peak productive ganglionic infection. A third possible
explanation is that inoculation with high titers of virus
effectively saturates the peripheral site of inoculation,
rapidly infecting most of the nerve terminals that project
to this site and leaving behind very few uninfected neu-
rons for subsequent infection by the progeny of periph-
eral viral replication. This scenario effectively “forces” an
early peak ganglionic infection.
In studying the effect of viral inoculum on the outcome
of ganglionic infection we also found that once over a
relatively small threshold, the size of the viral inoculum
had little effect on determining the efficiency of estab-
lishment of HSV latent infection. Support for this finding
comes from our analysis of the ratio of LAT-positive
neurons at 21 days p.i. to the number of HSV antigen-
positive neurons at the peak of ganglionic infection, a
ratio that was similar for all viral inocula tested. However,
with very low viral inocula, just above the threshold
needed in order to consistently establish latent gangli-
onic infection (;100 PFU), we observed a concentration-
dependent drop in the viral DNA content and number of
LAT-positive neurons in latently infected TG. This result
was similar to that observed by Sawtell using contextual
analysis (Sawtell, 1997, 1998). A likely explanation is that
at these very low viral inocula, the ganglia of some mice
within an experimental group do not become infected at
all, probably a consequence of the inherent variability of
the inoculation procedure.
SCID mice, which lack functional B and T lymphocytes,
are unable to clear productive HSV infection and die as
early as 7 days after peripheral infection with HSV (Mi-
nagawa et al., 1988; Valyi-Nagy et al., 1992). Our studies
on the establishment of latent infection in the TG of mice
lacking functional B and T lymphocytes (SCID mice)
TABLE 5
HSV LAT RNA Content in Trigeminal Ganglia of Latently Infected
Resistant, Sensitive, and Immunodeficient Mice
Mouse strain (n) a
Copies per
trigeminal ganglion
(log10 values)
b
Range
(log10 values)
57BL/6 (13) 7.0 6 0.5 6.3–7.6
KO (11) 7.0 6 0.7 6.2–8.1
eige (11) 6.8 6 0.7 6.1–8.2
wiss–Webster (11) 7.1 6 0.4 6.6–7.8
ALB/c (11) 7.3 6 0.5 6.6–8.3
BA (8) 6.5 6 0.3 6.1–6.8
a Number of trigeminal ganglia assayed by Q-RT-PCR.
b Mean 6 standard deviation.confirmed and extended earlier work by Gesser et al.
(1994). However, unlike these earlier studies, our workfocused on very early time points (2–4 days p.i.), allowing
us to demonstrate that not only is latency established as
efficiently in the TG of SCID mice as in immunocompe-
tent controls, but with the same kinetics. Based on these
data we conclude that B and T lymphocytes play little, if
any, role in the establishment of HSV latent infection.
This is not surprising since HSV establishes a latent
infection in TG neurons as early as 2 days p.i., long
before the adaptive immune response to HSV has time to
develop (Schmid and Rouse, 1992; Simmons et al., 1992).
Although it would have been useful to study HSV latent
infection in the TG of SCID mice in the absence of a
simultaneous productive infection, enabling us to com-
pare the latent viral load of control and experimental
ganglia by Q-PCR, this was untenable due to the uncon-
trolled, and invariably lethal, productive infection that
kills these mice as early as 5 days p.i. (Minagawa et al.,
988; Valyi-Nagy et al., 1992).
IFN-g plays an important role in controlling viral repli-
ation and clearance of infected cells during productive
SV infection (Bouley et al., 1995; Feduchi et al., 1989;
Geiger et al., 1994; Smith et al., 1994). Consistent with
this we found a greater number of HSV-antigen-positive
trigeminal neurons in GKO mice than in control mice
during productive infection. However, at 21 days p.i., after
productive infection had completely resolved, we found
similar numbers of LAT-positive trigeminal neurons in
GKO mice and in controls. It is notable that we found
about twofold more HSV DNA in the TG of GKO mice than
in controls, a difference that was statistically significant.
Since the number of LAT-positive neurons was similar in
the two mouse lines, the difference in latent DNA content
in the TG of GKO and control mice reflects either a
greater copy number of HSV genomes in each latently
infected neuron or a greater number of latently infected
neurons that express LAT below the limits of detection of
our in situ hybridization assay (Maggioncalda et al., 1996;
Mehta et al., 1995; Ramakrishnan et al., 1996). We find the
first of these explanations plausible given the role of
IFN-g in controlling viral replication (Feduchi et al., 1989).
n contrast, we find the second explanation to be unlikely,
ince this would require a greater than twofold increase
n the number of LAT-negative latently infected neurons
n the absence of any change in the number of LAT-
ositive neurons.
The importance of NK cells in controlling HSV infection
n vivo is not well established. NK cells are able to lyse
SV-1-infected target cells in vitro (Bishop et al., 1987;
Canessa et al., 1990; Colmenares and Lopez, 1986) and
passive transfer of NK cells to mice with cyclophospha-
mide-induced immunosuppression protects them from
lethal HSV infection (Rager-Zisman et al., 1987). How-
ever, mice with the beige mutation and anti-asialo GM1-
treated (to block NK cell activity) mice are reported to
have no greater susceptibility to lethal HSV infection than
control mice (Bukowski and Welsh, 1986; Morahan et al.,
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24 ELLISON ET AL.1982). In our studies of HSV infection of beige and control
mice we found similar numbers of productively infected
trigeminal neurons, but noted a one-day delay in the
peak day of infection in the beige mice. Delayed clear-
ance of pathogens in beige mice has been attributed to
abnormal lysosomal trafficking in NK cells and also to
deficiencies in polymorphonuclear leukocyte granulo-
cyte function and macrophage cytolytic activity (Barbosa
et al., 1996; Gallin et al., 1974; Hoskin et al., 1991; Ma-
oney et al., 1980; Perou et al., 1997). However, despite
he complex nature of the immunodeficiency of beige
ice, we found that latent HSV infection in these animals
as established as efficiently as in controls. We con-
lude that the NK cell function modulated by the beige
ene plays little role in the establishment of latent HSV
nfections. This does not rule out the possibility that NK
ell functions mediated by other molecules, such as
erforin (Ka¨gi et al., 1994), might still be involved.
Our studies of establishment of latent HSV infection in
ice with different genetic susceptibilities to acute HSV
nfection further support the notion that mechanisms that
imit productive HSV infection play little or no role in the
stablishment of HSV latency. We were particularly sur-
rised that the latent viral load of C57BL/6 mice was as
xtensive as that of the other strains tested since
57BL/6 mice are particularly resistant to lethal HSV
nfection (Kastrukoff et al., 1986; Lopez, 1975), and in this
tudy we observed fewer productively infected neurons
n the TG of these mice than in the other strains. The
elatively large latent viral load that we found in the TG of
57BL/6 mice is in apparent contrast to that previously
escribed by other investigators (Abghari and Stulting,
986; 1988; Kastrukoff et al., 1986). However, it is impor-
ant to point out that these investigators’ conclusions
ere based on in vitro reactivation of HSV from latently
nfected ganglia rather than Q-PCR, a more direct mea-
ure of latent viral load.
Although we have demonstrated that efficient estab-
ishment of HSV latent infection is not dependent on B
nd T lymphocytes, IFN-g, and the NK cell functions
mediated by the beige gene, our results leave open a
role for other components of the immune system in
modulating establishment of HSV latency. Using our
study as a model it would be interesting to examine
establishment of HSV latency in other immunodeficient
mice such as those lacking interferon-a/b, perforin, com-
plement protein C5, and specific cytokines. Studies by
other investigators have shown that macrophages and
certain cytokines (IL-4, IL-6, IL-10, RANTES) are promi-
nent in HSV-infected TG at 5–120 days p.i. (Halford et al.,
1997; Liu et al., 1996; Shimeld, 1997). Moreover, in vivo
depletion of macrophages and inhibition of TNF-a and
nducible nitric oxide synthase activity lead to increased
SV titers in productively infected TG (Kodukula et al.,
999). However, in order to give serious consideration to
he concept that other components of the immune sys-em play an important role in modulating the establish-
ent of latent HSV infection it would be important to
how that they are present (spatially and temporally)
uring the period of establishment, i.e., at 2–4 days p.i.,
hen many of the neurons of sensory ganglia appear to
ecome latently infected.
In view of the complex mix of leukocytes and cytokines
hat accumulates in sensory ganglia shortly after infec-
ion with HSV, sorting out whether any one component of
he immune system plays a critical role in the efficient
stablishment of latent HSV infection will be a difficult
ask. This endeavor is made even more difficult by the
edundant role that some of these factors are likely to
lay in guarding the host against viral infection. For
xample, murine thymocytes have been reported to me-
iate a natural killer-like activity against HSV-infected
ells (Tang et al., 1986) and both IFN and TNF inhibit viral
eplication (Feduchi et al., 1989). For these reasons fur-
her investigation of the role of the immune response on
stablishment of HSV latent infection will likely require
se of mice depleted of multiple populations of leuko-
ytes and/or with multiple genetic defects of the immune
esponse.
In summary, through the use of immunodeficient and
nbred mouse strains we have shown that a number of
omponents of the immune system, while essential for
ontaining and clearing productive infection with HSV,
re not required for efficient establishment of HSV latent
nfection. The results are consistent with growing evi-
ence that establishment of HSV latent infection of sen-
ory neurons is a consequence of specific virus–neuron
nteractions rather than immune-mediated events.
MATERIALS AND METHODS
iral stocks
HSV-1 strain KOS and the HSV-1 construct KOS/62,
hich carries the Escherichia coli lacZ gene inserted
immediately downstream of both copies of the LAT pro-
moter (Margolis et al., 1992), were propagated in rabbit
skin cells (RSC) maintained in Eagle’s minimal essential
medium with Earle’s balanced salt solution supple-
mented with 5% fetal calf serum, 10 units/ml penicillin,
and 10 mg/ml streptomycin. Viral titers were determined
y plaque assay on RSC monolayers and were typically
1 3 108 PFU/ml. Viral stocks were stored in aliquots at
280°C.
Animals and ocular infection with HSV
Six-week-old female C57BL/6J, BALB/cJ, CBA/J, SCID
(BALB/cByJSmn-scid/J), GKO (C57BL/6J-Ifgtm1Ts), and
beige (C57BL/6J-bgJ/bgJ) mice were purchased from The
Jackson Laboratory (Bar Harbor, ME) and 6-week-old
female Swiss–Webster (Crl:CFW) mice were purchased
from Charles River Laboratories (Hollister, CA). Mice
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25ESTABLISHMENT OF LATENT HSV IN IMMUNODEFICIENT MICEwere housed in accordance with UCSF policy on animal
use. In preparation for ocular inoculation mice were
anesthetized by intraperitoneal injection of 1.5% pento-
barbital followed by bilateral topical administration of 1%
proparacaine. Following corneal scarification, eyes and
ocular adnexa were inoculated with 15 ml HSV stock per
eye.
Tissue preparation for immunohistochemistry and in
situ hybridization
Mice were euthanized by carbon dioxide inhalation
and then perfused through the left ventricle with 10 ml
phosphate-buffered saline (PBS) followed by 10 ml 4%
(wt/vol) paraformaldehyde in PBS. The TG from five mice
were combined and immersion fixed in 4% paraformal-
dehyde at 4°C. TG were fixed 30 min (for immunohisto-
chemistry) or 4–6 h (for in situ hybridization), equilibrated
with 10% (wt/vol) sucrose, embedded in OCT compound
(Miles, Elkhart IN), and frozen in liquid nitrogen. Serial
sections (6 mm) were cut with a cryostat and collected as
ive alternate sets onto Superfrost Plus slides (Fisher
cientific, Pittsburgh, PA). Slides were stored at 220°C
or immunohistochemistry and 270°C for in situ hybrid-
zation.
mmunohistochemistry
All tissue sections were initially incubated in 3% nor-
al goat serum with 0.1% Triton X-100 for 15 min. To stain
or HSV antigen, tissue sections were subsequently in-
ubated with fluorescein isothiocyanate (FITC)-labeled
abbit anti-HSV-1 (DAKO, Carpenteria, CA) diluted 1:200
n 1% normal goat serum for 40 min. For dual immuno-
luorescence studies [b-galactosidase (b-gal) and HSV
antigen] tissue sections were sequentially incubated
with biotinylated mouse anti-b–gal antisera diluted 1:700
or 1 h, Rhodamine600Avidin D (Vector Laboratories, Bur-
ingame, CA) diluted 1:1200 for 40 min, biotinylated goat
nti-Avidin D (Vector Laboratories) diluted 1:200 for 40
in, and again Rhodamine600Avidin D, followed by FITC-
labeled anti-HSV-1 as above. Slides were then washed
and mounted with glass coverslips using Vectashield
(Vector Laboratories). The numbers of HSV-1 antigen-
and b-gal-positive neurons were determined by fluores-
ence microscopy using a Nikon Microphot SA micro-
cope.
n situ hybridization
Plasmid ATD19, which contains a 347-bp fragment of
he stable LAT intron (HSV nucleotide positions 119,628
o 119,975), was linearized by restriction endonuclease
igestion with either EcoRI (sense probe) or HindIII (an-
isense probe), extracted with phenol:chloroform:isoamyl
lcohol (25:24:1, vol/vol), and precipitated with ethanol.
adiolabeled sense and antisense RNA probes were
repared by in vitro transcription using 35S-labeled UTP.
wIn situ hybridization was carried out according to Cun-
ningham and De Souza (1994). Briefly, tissue sections
were thawed; postfixed for 30 min in 10% (vol/vol) neutral-
buffered formalin; treated sequentially with 0.1 mg/ml
proteinase K, 0.25% (vol/vol) acetic anhydride in 0.1 M
triethanolamine; and dehydrated in ethanol. Riboprobes
were diluted to 107 cpm/ml in hybridization buffer [62.5%
vol/vol) formamide, 375 mM NaCl, 12.5 mM Tris–HCl (pH
.0), EDTA (pH 8.0), 1.253 Denhardt’s solution, 12.5%
wt/vol) dextran sulfate], applied to tissue sections, and
llowed to incubate at 60°C for 18–20 h. Sections were
hen treated with 20 mg/ml RNase A (Sigma Chemical
o., St. Louis, MO) and washed through concentrations
f NaCl–sodium citrate from 43 through 0.13. Sections
ere then dehydrated, dipped in Kodak nuclear emulsion
TB3 (Eastman Kodak, Rochester, NY), dried, exposed
or 2–14 days, developed, and counterstained with he-
atoxylin–eosin. The numbers of LAT-positive neurons
ere determined by light microscopy.
reparation of ganglionic DNA and RNA
At 21 days p.i. mice were euthanized by carbon dioxide
nhalation. The left and right ganglia were removed and
nap frozen in liquid nitrogen; the elapsed time from
ntroduction into the carbon dioxide chamber to immer-
ion of tissue into liquid nitrogen was less than 4 min.
NA and RNA were prepared from each ganglion using
RIzol reagent (Life Technologies, Gaithersberg, MD)
ccording to the manufacturer’s instructions. The DNA
raction was further purified by incubation in a solution
ontaining 0.1% (wt/vol) sodium dodecyl sulfate, 5 mM
DTA, 100 mM NaCl, 50 mM Tris–HCl (pH 7.4), and 0.1
g/ml proteinase K overnight at 50°C. The next day
Nase-free RNase A (Boehringer Mannheim, Indianap-
lis, IN) was added to a final concentration of 10 mg/ml
and the mixture was incubated 2 h at 37°C. The mixture
was phenol–chloroform extracted, ethanol precipitated,
and resuspended in 25 ml H2O. The RNA fraction was
urther purified by incubation at 37°C for 60 min in a
olution containing 0.8 U/ml RNase-free DNase I (Boehr-
nger Mannheim), 10 mM MgCl2, 0.1 mM DTT, and 0.7
U/ml RNase inhibitor (Boehringer Mannheim). RNA prep-
arations were extracted with phenol–chloroform, ethanol
precipitated, and then resuspended in diethyl pyrocar-
bonate-treated H2O. The concentration and purity of the
DNA and RNA preparations were determined from spec-
trophotometric determinations at 260 and 280 nm.
Q-PCR assay for viral DNA
Q-PCR was carried out according to the protocols of
Coen and colleagues (Katz et al., 1990; Kramer and Coen,
1995). Briefly, 2 ml ganglionic DNA (150 ng) was heated
nder mineral oil at 94°C for 10 min and then combined
ith 48 ml PCR mix containing 50 mM KCl, 10 mM
Tris–HCl (pH 9.0), 2.5 mM MgCl2, 0.2 mM each de-
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26 ELLISON ET AL.oxynucleotide triphosphate (dATP, dCTP, dGTP, dTTP), 0.1
mM sense and antisense oligonucleotides, 10% (vol/vol)
DMSO, 0.1% (vol/vol) Triton X-100, and 40 U/ml Taq poly-
merase (Perkin–Elmer, Foster City, CA). Oligonucleotide
primers were specific for HSV1-TK (sense, 59-CCA TCA
ACA CGC GTC TGC GTT CG-39; antisense, 59-CC AGT
AAG TCA TCG GCT CGG G-39) and mouse hypoxanthine
phophoribosyltransferase (HPRT) (sense, 59-GAG TTC
CGG AAC TGC CTT TGG TG-39; antisense, 59-CTG TGC
CAC CGG GCG CAT GG-39) sequences. The reactions
were incubated 94°C for 36 s and 65°C for 5 min for 34
cycles on a thermocycling dry block (Model PE9700,
Perkin–Elmer). As a final extension step, the reactions
were incubated at 65°C for 10 min. A 20-ml aliquot of the
polymerase chain reaction was subjected to electro-
phoresis through a 2% agarose gel containing 0.5 mg/ml
ethidium bromide. Gels were photographed and bands
representing HPRT and TK were quantified with Kodak
Digital Science 1D Image Analysis software (version 1.6).
TK readings were normalized to HPRT readings. Stan-
dard curves were drawn and read with Deltagraph (ver-
sion 2.0) software. Copy number standards for Q-PCR
were made using 0.075 mg/ml mouse brain DNA spiked
ith dilutions of the plasmid pTK1 (Wilkie et al., 1979).
SV DNA copies per trigeminal ganglion were trans-
ormed into log10 values for determination of mean and
standard deviation.
Q-RT-PCR for LAT RNA
First-strand cDNA was synthesized in a 20-ml reaction
ix containing 1.5 mg DNase-treated total cellular RNA,
0 mM Tris–HCl (pH 8.3), 75 mM KCl, 3 mM MgCl2, 10
M DTT, 0.2 mM each deoxynucleotide triphosphate
dATP, dCTP, dGTP, dTTP), 2.6 U/ml RNasin (Promega,
adison, WI), 1.0 mg random hexamer (Pharmacia), and
0 U/ml murine Moloney leukemia virus RT (Promega).
he mixture was incubated at 23°C for 10 min, 37°C for
5 min, 95°C for 5 min, and 18°C for 1 min. The reactions
ere immediately placed on ice and the reaction volume
as adjusted to 50 ml with H2O. PCR was carried out as
described above except that two reactions were run in
parallel. One reaction contained primers G3PDH-1 (59-
ACC ACA GTC CAT GCC ATC AC-39) and G3PDH-2 (59-
TCC ACC ACC CTG TTG CTG TA-39), which amplify a
452-bp fragment of the glyceraldehyde-3-phosphate de-
hydrogenase gene. The other contained primers LAT-3
and LAT-4 (Kramer and Coen, 1995), which amplify a
195-bp fragment of the 2.0-kb LAT RNA and require an
annealing temperature of 55°C. Gels were photo-
graphed, digitized, and analyzed as described above.
Copy number standards contained uninfected mouse
ganglionic RNA spiked with dilutions of in vitro-tran-
scribed DNase-treated LAT RNA. HSV LAT RNA copies
per trigeminal ganglion were transformed into log10 val-
es for determination of mean and standard deviation.ACKNOWLEDGMENTS
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